Giuseppe Celasco

485 total citations
25 papers, 391 citations indexed

About

Giuseppe Celasco is a scholar working on Genetics, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Giuseppe Celasco has authored 25 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Giuseppe Celasco's work include Inflammatory Bowel Disease (4 papers), Hormonal and reproductive studies (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Giuseppe Celasco is often cited by papers focused on Inflammatory Bowel Disease (4 papers), Hormonal and reproductive studies (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Giuseppe Celasco collaborates with scholars based in Italy, Austria and Switzerland. Giuseppe Celasco's co-authors include L. Moro, Luigi Moro, Maria Collu, Gian Luigi Gessa, Gino Serra, George‐Sorin Ţiplica, Cinzia Quattrocchi, Pejman Dehghanyar, M. Müller and Martin Brunner and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and British Journal of Dermatology.

In The Last Decade

Giuseppe Celasco

22 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Celasco Italy 13 118 90 81 71 40 25 391
Halit Oğuz Türkiye 14 42 0.4× 61 0.7× 58 0.7× 55 0.8× 53 1.3× 65 716
Mylène Vivinus-Nébot France 7 150 1.3× 82 0.9× 100 1.2× 160 2.3× 167 4.2× 10 673
Portia Goldsmith United Kingdom 10 22 0.2× 119 1.3× 163 2.0× 25 0.4× 37 0.9× 26 425
Surabhi Sinha India 12 32 0.3× 117 1.3× 183 2.3× 60 0.8× 45 1.1× 71 601
K. Bjerrum Denmark 8 17 0.1× 25 0.3× 56 0.7× 34 0.5× 40 1.0× 23 500
Fatma Markoç Türkiye 12 24 0.2× 78 0.9× 56 0.7× 75 1.1× 73 1.8× 30 422
Anjona Schmidt‐Choudhury Germany 14 28 0.2× 27 0.3× 55 0.7× 179 2.5× 68 1.7× 36 521
Aleksandra Vojvodić Serbia 14 18 0.2× 70 0.8× 314 3.9× 35 0.5× 66 1.6× 72 605
Jiajing Lu China 12 33 0.3× 31 0.3× 115 1.4× 25 0.4× 131 3.3× 61 533
W. Busse United States 12 34 0.3× 96 1.1× 24 0.3× 72 1.0× 87 2.2× 27 747

Countries citing papers authored by Giuseppe Celasco

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Celasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Celasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Celasco more than expected).

Fields of papers citing papers by Giuseppe Celasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Celasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Celasco. The network helps show where Giuseppe Celasco may publish in the future.

Co-authorship network of co-authors of Giuseppe Celasco

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Celasco. A scholar is included among the top collaborators of Giuseppe Celasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Celasco. Giuseppe Celasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Celasco, Giuseppe, et al.. (2014). Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties. Biomedical Reports. 2(4). 559–563. 12 indexed citations
2.
Rosette, Caridad, et al.. (2013). Anti-inflammatory and immunomodulatory activities of rifamycin SV. International Journal of Antimicrobial Agents. 42(2). 182–186. 16 indexed citations
3.
4.
Celasco, Giuseppe, et al.. (2011). Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist. Arzneimittelforschung. 54(12). 881–886. 17 indexed citations
5.
Celasco, Giuseppe, Luigi Moro, Patrizia Ferraboschi, et al.. (2011). Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity. Arzneimittelforschung. 55(10). 581–587.
6.
Farrell, David J., Shannon D. Putnam, Douglas J. Biedenbach, et al.. (2010). In Vitro Activity and Single-Step Mutational Analysis of Rifamycin SV Tested against Enteropathogens Associated with Traveler's Diarrhea and Clostridium difficile. Antimicrobial Agents and Chemotherapy. 55(3). 992–996. 14 indexed citations
7.
Celasco, Giuseppe, Alfredo Papa, Rena R. Jones, et al.. (2009). Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX®) for active left‐sided ulcerative colitis. Alimentary Pharmacology & Therapeutics. 31(3). 375–386. 26 indexed citations
8.
Quattrocchi, Cinzia, et al.. (2009). P308 - Rifamycin SV: evaluation of the activity in DNB-induced colitis in rats and on IFNγ production in ConA-stimulated rat splenocytes. Journal of Crohn s and Colitis. 3(1). S131–S132. 2 indexed citations
9.
Pastorelli, Luca, Simone Saibeni, Luisa Spina, et al.. (2008). Oral, colonic‐release low‐molecular‐weight heparin: an initial open study of Parnaparin‐MMX for the treatment of mild‐to‐moderate left‐sided ulcerative colitis. Alimentary Pharmacology & Therapeutics. 28(5). 581–588. 35 indexed citations
10.
Celasco, Giuseppe, Luigi Moro, Katia Mangano, et al.. (2008). Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat. Digestive Diseases and Sciences. 53(12). 3170–3175. 20 indexed citations
11.
Rosette, Caridad, et al.. (2008). P274 IMMUNOMODULATORY EFFECTS OF A LOW MOLECULAR WEIGHT HEPARIN (CB-01-05). Zenodo (CERN European Organization for Nuclear Research). 2(1). 85–85. 1 indexed citations
12.
13.
Brunner, Martin, S. Ziegler, Pejman Dehghanyar, et al.. (2005). Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. British Journal of Clinical Pharmacology. 61(1). 31–38. 75 indexed citations
14.
Lotti, Torello, Giuseppe Celasco, Patrizia Teofoli, et al.. (1993). MESOGLYCAN TREATMENT RESTORES DEFECTIVE FIBRINOLYTIC POTENTIAL IN CUTANEOUS NECROTIZING VENULITIS. International Journal of Dermatology. 32(5). 368–371. 9 indexed citations
15.
Celasco, Giuseppe, et al.. (1983). Actions of microelectrophoretically applied glucocorticoid hormones on reticular formation neurones in the rat. Neuroscience Letters. 38(1). 45–49. 19 indexed citations
16.
Serra, Gino, et al.. (1983). Hypophysectomy prevents yawning and penile erection but not hypomotility induced by apomorphine. Pharmacology Biochemistry and Behavior. 19(6). 917–919. 54 indexed citations
17.
Gladiali, Serafino, et al.. (1977). Antiinflammatory activity of 17-esters of 6.alpha.,9.alpha.-difluoro-21-deoxyprednisolone. Journal of Medicinal Chemistry. 20(6). 853–854.
18.
Gladiali, Serafino, et al.. (1977). Disteroidyl ethers. 1. Synthesis and oral long-lasting uterotrophic activity of 1,3,5(10)-estratrien-17-yl enol ethers of 3-ketosteroids. Journal of Medicinal Chemistry. 20(3). 359–364. 2 indexed citations
19.
Galletti, Ferruccio, et al.. (1972). Oral long-lasting estrogenic activity of estradiol 3-benzoate 17-cyclooctenyl ether. Steroids. 20(5). 627–638. 5 indexed citations
20.
Celasco, Giuseppe, et al.. (1968). [Preliminary research with an original microiontophoretic method on the functional meaning of chemical transmitters at the level of the single atrial cell in the rabbit heart].. PubMed. 44(5). 450–2.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halit Oğuz Breakdown of academic impact, for papers by Mylène Vivinus-Nébot Breakdown of academic impact, for papers by Portia Goldsmith Breakdown of academic impact, for papers by Surabhi Sinha Breakdown of academic impact, for papers by K. Bjerrum Breakdown of academic impact, for papers by Fatma Markoç Breakdown of academic impact, for papers by Anjona Schmidt‐Choudhury Breakdown of academic impact, for papers by Aleksandra Vojvodić Breakdown of academic impact, for papers by Jiajing Lu Breakdown of academic impact, for papers by W. Busse
Rankless by CCL
2026